OBJECTIVE: To describe the 12-month and lifetime prevalence rates of pure and comorbid mental disorders in Belgium. METHOD: A representative random sample of non-institutionalized inhabitants from Belgium aged 18 or older (N = 2419) was interviewed between April 2001 and June 2002. DSM-IV disorders were assessed by lay interviewers using a revised version of the Composite International Diagnostic Interview (CIDI-2000). RESULTS: More than 27% reported a lifetime history of at least one mental disorder; one in nine reported the presence of a mental disorder in the past 12 months. Major depressive disorder (MDD) and alcohol abuse were the most common lifetime disorders; MDD and specific phobia were most common in the past 12 months. Psychiatric comorbidity was also a common condition. CONCLUSION: Psychiatric disorders in Belgium are frequent. More than two million Belgians have had a mental disorders at a certain moment in their life; more than 800,000 have had a mental disorder in the past 12 months.
OBJECTIVE: To describe the 12-month and lifetime prevalence rates of pure and comorbid mental disorders in Belgium. METHOD: A representative random sample of non-institutionalized inhabitants from Belgium aged 18 or older (N = 2419) was interviewed between April 2001 and June 2002. DSM-IV disorders were assessed by lay interviewers using a revised version of the Composite International Diagnostic Interview (CIDI-2000). RESULTS: More than 27% reported a lifetime history of at least one mental disorder; one in nine reported the presence of a mental disorder in the past 12 months. Major depressive disorder (MDD) and alcohol abuse were the most common lifetime disorders; MDD and specific phobia were most common in the past 12 months. Psychiatric comorbidity was also a common condition. CONCLUSION:Psychiatric disorders in Belgium are frequent. More than two million Belgians have had a mental disorders at a certain moment in their life; more than 800,000 have had a mental disorder in the past 12 months.
Authors: J Breslau; E Miller; R Jin; N A Sampson; J Alonso; L H Andrade; E J Bromet; G de Girolamo; K Demyttenaere; J Fayyad; A Fukao; M Gălăon; O Gureje; Y He; H R Hinkov; C Hu; V Kovess-Masfety; H Matschinger; M E Medina-Mora; J Ormel; J Posada-Villa; R Sagar; K M Scott; R C Kessler Journal: Acta Psychiatr Scand Date: 2011-04-30 Impact factor: 6.392